A Computer-Aided System for Determining the Application Range of a Warfarin Clinical Dosing Algorithm Using Support Vector Machines with a Polynomial Kernel Function
暂无分享,去创建一个
Houshang Darabi | Ashkan Sharabiani | William L. Galanter | Adam Bress | Rezvan Nazempour | W. Galanter | H. Darabi | A. Bress | Ashkan Sharabiani | Rezvan Nazempour
[1] Lesley G Mitchell,et al. In pediatric patients, age has more impact on dosing of vitamin K antagonists than VKORC1 or CYP2C9 genotypes. , 2010, Blood.
[2] S. Shaughnessy,et al. Do No Harm: Health Systems’ Duty to Promote Clinician Well-Being , 2022, American Journal of Hospital Medicine.
[3] Bin Jiang,et al. Evolutionary Ensemble Learning Algorithm to Modeling of Warfarin Dose Prediction for Chinese , 2019, IEEE Journal of Biomedical and Health Informatics.
[4] Vladimir Vapnik,et al. Statistical learning theory , 1998 .
[5] E. Merriman,et al. Bleeding risk with dabigatran in the frail elderly. , 2012, The New England journal of medicine.
[6] M Gent,et al. Incidence of recurrent thromboembolic and bleeding complications among patients with venous thromboembolism in relation to both malignancy and achieved international normalized ratio: a retrospective analysis. , 2000, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[7] Houshang Darabi,et al. Machine learning based prediction of warfarin optimal dosing for African American patients , 2013, 2013 IEEE International Conference on Automation Science and Engineering (CASE).
[8] F. Kamali,et al. Warfarin Dose Model for the Prediction of Stable Maintenance Dose in Indian Patients , 2018, Clinical and applied thrombosis/hemostasis : official journal of the International Academy of Clinical and Applied Thrombosis/Hemostasis.
[9] Mohammad Karim Sohrabi,et al. Multi-objective feature selection for warfarin dose prediction , 2017, Comput. Biol. Chem..
[10] Stephen E Kimmel,et al. Ethnic differences in warfarin maintenance dose requirement and its relationship with genetics. , 2008, Pharmacogenomics.
[11] Christine W. Duarte,et al. High-dimensional pharmacogenetic prediction of a continuous trait using machine learning techniques with application to warfarin dose prediction in African Americans , 2011, Bioinform..
[12] M. Whirl‐Carrillo,et al. Clinical Pharmacogenetics Implementation Consortium Guidelines for CYP2C9 and VKORC1 Genotypes and Warfarin Dosing , 2011, Clinical pharmacology and therapeutics.
[13] C. Richards,et al. Emergency hospitalizations for adverse drug events in older Americans. , 2011, The New England journal of medicine.
[14] M. Pirmohamed,et al. Genotype-guided dosing of coumarin derivatives: the European pharmacogenetics of anticoagulant therapy (EU-PACT) trial design. , 2009, Pharmacogenomics.
[15] Jean-Louis Golmard,et al. Vitamin K antagonists in children with heart disease: height and VKORC1 genotype are the main determinants of the warfarin dose requirement. , 2012, Blood.
[16] F. Kamali,et al. VKORC1 and CYP2C9 genotype and patient characteristics explain a large proportion of the variability in warfarin dose requirement among children. , 2012, Blood.
[17] A. Thompson,et al. Genetic and Clinical Determinants Influencing Warfarin Dosing in Children With Heart Disease , 2013, Pediatric Cardiology.
[18] Tugba Taskaya-Temizel,et al. A Bayesian Estimation Framework for Pharmacogenomics Driven Warfarin Dosing: A Comparative Study , 2015, IEEE Journal of Biomedical and Health Informatics.
[19] Jeffrey L. Anderson,et al. Statistical design of personalized medicine interventions: The Clarification of Optimal Anticoagulation through Genetics (COAG) trial , 2010, Trials.
[20] J. de Lemos,et al. Emergency hospitalizations for adverse drug events. , 2012, The New England journal of medicine.
[21] Houshang Darabi,et al. A New Approach towards Minimizing the Risk of Misdosing Warfarin Initiation Doses , 2018, Comput. Math. Methods Medicine.
[22] L. Cavallari,et al. Warfarin Pharmacogenetics: To Genotype or Not to Genotype, That Is the Question , 2014, Clinical pharmacology and therapeutics.
[23] Stuart A Scott,et al. Warfarin pharmacogenetic trials: is there a future for pharmacogenetic-guided dosing? , 2014, Pharmacogenomics.
[24] Houshang Darabi,et al. Revisiting Warfarin Dosing Using Machine Learning Techniques , 2015, Comput. Math. Methods Medicine.
[25] Masato Taguchi,et al. Effect of the VKORC1 genotype on warfarin dose requirements in Japanese pediatric patients. , 2011, Drug metabolism and pharmacokinetics.
[26] J N Douglas,et al. Ethnicity-specific pharmacogenetics: the case of warfarin in African Americans , 2013, The Pharmacogenomics Journal.
[27] M. Rieder,et al. Use of Pharmacogenetic and Clinical Factors to Predict the Therapeutic Dose of Warfarin , 2008, Clinical pharmacology and therapeutics.
[28] Yuchiao Chang,et al. Effect of intensity of oral anticoagulation on stroke severity and mortality in atrial fibrillation. , 2003, The New England journal of medicine.
[29] Valentin Fuster,et al. American Heart Association/American College of Cardiology Foundation guide to warfarin therapy. , 2003, Circulation.
[30] Mario Plebani,et al. VKORC1, CYP2C9 and CYP4F2 genetic-based algorithm for warfarin dosing: an Italian retrospective study. , 2011, Pharmacogenomics.
[31] Jie Chen,et al. Warfarin maintenance dose Prediction for Patients undergoing heart valve replacement— a hybrid model with genetic algorithm and Back-Propagation neural network , 2018, Scientific Reports.
[32] C. Thorn,et al. Dosing Algorithms to Predict Warfarin Maintenance Dose in Caucasians and African Americans , 2008, Clinical pharmacology and therapeutics.